<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="119438">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02030470</url>
  </required_header>
  <id_info>
    <org_study_id>5716</org_study_id>
    <nct_id>NCT02030470</nct_id>
  </id_info>
  <brief_title>Evaluation of Photodynamic Treatment FOTOSAN® Efficacy in Periodontology</brief_title>
  <official_title>Evaluation of Photodynamic Treatment FOTOSAN® Efficacy in Periodontology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <authority>France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Periodontitis are infectious and inflammatory diseases of gum and tooth supporting tissues
      leading to tooth loss and oral disability. Twenty to 30 percents of patients treated for
      periodontal diseases display more or less pronounced persistence of periodontal tissue
      infection, inflammation, and destruction. The therapeutic additional value of photodynamic
      anti-infectious treatment remains controversial. The objective of this study is to evaluate
      the mid-term effect of the photodynamic device Fotosan®630 on severe periodontitis treatment
      outcomes and to define its specific therapeutic indications.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">March 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change of periodontal pocket depth</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Study period for each participant : 6 months Inclusion period: 24 monthTotal study duration: 30 month</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of periodontal clinical attachment level, gingival inflammation and dental plaque indexChange of periodontal microflora</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Periodontitis</condition>
  <arm_group>
    <arm_group_label>fotosan</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fotosan®630. LED lamp. Toluidinblue. Photoactivated disinfection</intervention_name>
    <arm_group_label>fotosan</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  aged 40 years

          -  signed informed consent

          -  generalized severe chronic periodontitis

          -  patient with at least 24 teeth

          -  more than 30% of sites with clinical attachment loss &gt;5mm- at least 5 sites with
             pocket depth &gt;4mm per quadrant- at least one molar per quadrant- evidenced bone loss
             on radiographs- bleeding on probing ≥30%

        Exclusion Criteria:

          -  aggressive periodontitis

          -  smoking more than 10cig/day

          -  patient with endocarditis risk or need of antibiotic prophylaxis

          -  pregnant women

          -  patient included in other trials

          -  patient under guardianship

          -  patient treated with antibiotics, anti-inflammatory, and other drugs (inhibitors of
             calcium channels…) influencing periodontal status within 6 months before examination

          -  patient suffering from diseases influencing periodontal status (diabetes…)

          -  patient periodontally treated with root planing or periodontal surgery within 1 year
             before examination

          -  patient with scheduled extensive prosthetic treatment

          -  patient with a high haemorrhagic risk (INR&gt;4)

          -  impossible patient cooperation
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Luc Davideau, MDPHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Les Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christine Geiller</last_name>
    <phone>0033388115266</phone>
    <email>drci@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Service de parodontologie</name>
      <address>
        <city>Strasbourg</city>
        <state>Alsace</state>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Jean-Luc Davideau, MD PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>January 6, 2014</lastchanged_date>
  <firstreceived_date>December 16, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Periodontitis, treatment, photodynamic, mid-term, bacteria</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Periodontitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
